Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Ewalt

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Blood Cancer Journal|August 29, 2025
Treatment outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg-type in the rituximab eraGiulio Cassanello, Esther Drill, Annie Qiu, et al.
The Journal of Molecular Diagnostics : JMD|December 16, 2023
Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing-Based Clonality Testing in B-Cell and Plasma Cell NeoplasmsYing Liu, Caleb Ho, Wayne Yu, et al.
The Journal of Molecular Diagnostics : JMD|May 17, 2025
Leveraging RNA from DNA Extraction Lysate to Rescue "Insufficient" Samples for More Comprehensive Genomic Profiling in Patients with Scant Tumor SpecimensMark D Ewalt, Sara E DiNapoli, Kerry Mullaney, et al.
Blood Cancer Journal|June 16, 2026
Detection of MEN1 resistance mutations in cell-free DNA from acute leukemia patients treated with menin inhibitorsNeerav Shukla, Karmelina Charalambous, Shanita Li, et al.
Blood Advances|October 25, 2019
Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemiaAmanda C Winters, Jonathan A Gutman, Enkhtsetseg Purev, et al.
Blood Advances|September 10, 2021
Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistanceJustin Anthony Chen, Yanli Hou, Krishna M Roskin, et al.
The Journal of Molecular Diagnostics : JMD|December 15, 2019
Multi-Institutional Evaluation of Interrater Agreement of Variant Classification Based on the 2017 Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in CancerDeepika Sirohi, Robert L Schmidt, Dara L Aisner, et al.
The Journal of Molecular Diagnostics : JMD|March 24, 2023
Clonal Characterization and Somatic Hypermutation Assessment by Next-Generation Sequencing in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Detailed Description of the Technical Performance, Clinical Utility, and Platform ComparisonKseniya Petrova-Drus, Mustafa Syed, Wayne Yu, et al.
Haematologica|April 4, 2024
Universal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippingsOzge Ceyhan-Birsoy, Elise Fiala, Satshil Rana, et al.
Haematologica|March 7, 2024
Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignanciesMelissa Krystel-Whittemore, Kseniya Petrova-Drus, Ryan N Ptashkin, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Blood Cancer Journal|August 29, 2025
Treatment outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg-type in the rituximab eraGiulio Cassanello, Esther Drill, Annie Qiu, et al.
The Journal of Molecular Diagnostics : JMD|December 16, 2023
Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing-Based Clonality Testing in B-Cell and Plasma Cell NeoplasmsYing Liu, Caleb Ho, Wayne Yu, et al.
The Journal of Molecular Diagnostics : JMD|May 17, 2025
Leveraging RNA from DNA Extraction Lysate to Rescue "Insufficient" Samples for More Comprehensive Genomic Profiling in Patients with Scant Tumor SpecimensMark D Ewalt, Sara E DiNapoli, Kerry Mullaney, et al.
Blood Cancer Journal|June 16, 2026
Detection of MEN1 resistance mutations in cell-free DNA from acute leukemia patients treated with menin inhibitorsNeerav Shukla, Karmelina Charalambous, Shanita Li, et al.
Blood Advances|October 25, 2019
Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemiaAmanda C Winters, Jonathan A Gutman, Enkhtsetseg Purev, et al.
Blood Advances|September 10, 2021
Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistanceJustin Anthony Chen, Yanli Hou, Krishna M Roskin, et al.
The Journal of Molecular Diagnostics : JMD|December 15, 2019
Multi-Institutional Evaluation of Interrater Agreement of Variant Classification Based on the 2017 Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in CancerDeepika Sirohi, Robert L Schmidt, Dara L Aisner, et al.
The Journal of Molecular Diagnostics : JMD|March 24, 2023
Clonal Characterization and Somatic Hypermutation Assessment by Next-Generation Sequencing in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Detailed Description of the Technical Performance, Clinical Utility, and Platform ComparisonKseniya Petrova-Drus, Mustafa Syed, Wayne Yu, et al.
Haematologica|April 4, 2024
Universal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippingsOzge Ceyhan-Birsoy, Elise Fiala, Satshil Rana, et al.
Haematologica|March 7, 2024
Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignanciesMelissa Krystel-Whittemore, Kseniya Petrova-Drus, Ryan N Ptashkin, et al.
Pageof 5